Marketwired Hawaii Biotech Initiates Phase 1 Clinical Trial for Dengue Vaccine
Hawaii Biotech's Marissa Torio finalizes the purification of the active dengue vaccine product which involves a buffer exchange into a stable solution suitable for long term storage. (photo courtesy of Hawaii Biotech, Inc.)      
Return to Release | Remove Frame | Source Image available